Back
Larimar Therapeutics, Inc. 10K Form
Sell
46
LRMR
Larimar Therapeutics, Inc.
Last Price:
$3.81
Seasonality Move:
40.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LRMR News And Ratings
See the #1 stock for the next 7 days that we like better than LRMR
LRMR Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-28.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.62 |
| Price / Book: | 2.28 |
Profitability
| EPS (TTM): | -1.92760 |
|---|---|
| Net Income (TTM): | $-132M |
| Gross Margin: | $-318K |
| Return on Equity: | -85.34% |
| Return on Assets: | -71.16% |
Larimar Therapeutics, Inc. Earnings Forecast
Key Larimar Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 3 years.
Larimar Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LRMR |
| CUSIP: | 517125 |
| Website: | larimartx.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 4.06 |
| Quick Ratio: | 3.89 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LRMR Technical Analysis vs Fundamental Analysis
Sell
46
Larimar Therapeutics, Inc. (LRMR)
is a Sell
Is Larimar Therapeutics, Inc. a Buy or a Sell?
-
Larimar Therapeutics, Inc. stock is rated a SellThe current Larimar Therapeutics, Inc. [LRMR] share price is $3.70. The Score for LRMR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.